Board Appointment

Advanced Medical Solutions Grp PLC
20 February 2007


For Immediate Release                                           20 February 2007

                      Advanced Medical Solutions Group plc
                            ('AMS' or 'the Company')

                     Appointment of Non-Executive Director

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global
medical technology company, today announces that Mr Stephen Gerard Bellamy, a
chartered accountant with extensive City experience, has been appointed to the
Board as a Non-Executive Director with immediate effect.

Mr Bellamy, aged 47, is currently Chairman of The First Close Technology Fund,
which is managed by Close Brothers and invests in early stage UK technology
companies. He is also a Non-Executive Director of Unifisoft Limited, a
technology supplier to the financial services industry, and QBM Limited, a
non-trading company.

Mr Bellamy, who qualified as a chartered accountant in New Zealand in 1984, was 
an Executive Director of Sherwood International plc from 1994 to 2001, where he 
was CFO and then COO of the global business operations of the group.  He was 
also previously an Executive Director of Brierley Investments' London operations 
from 1986 to 1993.

Mr Bellamy's previous non-executive directorships have included Dr Foster Limited, 
a provider of informatics to the UK health industry with a strong presence in 
the NHS; CSols plc, a laboratory software and services company; and Budgens 
plc, the food retailer acquired in 2002 by Musgrave Group for £315 million. 
In addition, Mr Bellamy is a former Member of the Advisory Committee to ISIS 
Capital plc.

Commenting on this announcement Dr Geoffrey N Vernon, Non-Executive Chairman of
AMS, stated: 'I am delighted to welcome Stephen to our Board. His strong City
experience will be of great value to AMS as we develop the Company further and
continue to look for strategic corporate opportunities to enhance growth.'

Mr Bellamy's other previous non-executive directorships during the past five 
years comprise: QBM Holdings Limited; GTJST Limited, formerly named IQA Holdings 
Limited; and Force 12 Holdings Limited.

There are no further disclosures to be made with regards to this appointment 
under paragraph (g) of Schedule 2 of the AIM Rules.

For further information, please contact:

Advanced Medical Solutions Group plc         Tel : [phone]

Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com

Buchanan Communications                      Tel: [phone]
Mark Court, Mary-Jane Johnson

Notes for Editors:

About Advanced Medical Solutions

Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $13 billion global woundcare market.

Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.

In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.

The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives that offer benefits over sutures and
staples for closing wounds sold direct to hospitals or through distributors.

AMS's technology and products currently serve the majority of the key global
markets and strategic partners.





                      This information is provided by RNS
            The company news service from the London Stock Exchange